← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
21st Century Therapeutics, Inc.
Shelby Township, MI
$3,273,236
Total funding
8
Grants
Funding over time
peak $778.4K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,273,236 · 8
By mechanism
R43$1,952,701 · 6
R44$1,133,678 · 1
N43$186,857 · 1
Investigators at 21st Century Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel small-molecule TNF-a modulators as chemoprotective agents$591,522
R44 · FY2011 · CA
Novel small-molecule TNF-a modulators as chemoprotective agents$542,156
R44 · FY2012 · CA
Development of a Novel Small Molecule as a Radioprotector for Total Body Irradiation$345,914
R43 · FY2018 · HL
Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors$338,736
R43 · FY2014 · GM
Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors$335,740
R43 · FY2015 · GM
Novel Compounds from Sycamore Leaves for the Treatment of MRSA$303,745
R43 · FY2015 · AT
Development of a novel small molecule, UTL-5g, to treat oxaliplatin-induced throm$276,418
R43 · FY2013 · CA
Synthesis/In Vivo Activity of Cyclocinamide A$192,512
R43 · FY2005 · CA
TAS::75 0849::TAS$186,857
N43 · FY2011 · CA
Novel Small-molecule TNF-a Modulators as Chemoprotective Agents$154,852
R43 · FY2009 · CA
Novel Compounds from Sycamore Leaves for the Treatment of MRSA$4,784
R43 · FY2016 · AT